keyword
https://read.qxmd.com/read/38710533/oocyte-cryopreservation-for-women-with-endometriosis-justification-indications-and-reproductive-outcomes
#1
JOURNAL ARTICLE
Seung Joo Chon, Byung Chul Jee
Women with endometriosis often experience diminished ovarian reserve and a decreased number of oocytes retrieved. This reduction is exacerbated after surgery. Nevertheless, oocyte quality does not seem to be compromised in these patients. When embryos of good quality are obtained, in vitro fertilization outcomes are generally satisfactory. Oocyte cryopreservation may represent a fertility preservation option for women with planned and/or prior surgery, as it enables the collection of oocytes in advance. Given the diverse manifestations of endometriosis, which vary by type, age, and ovarian reserve, the decision to pursue oocyte cryopreservation should be weighed individually...
May 7, 2024: Clinical and Experimental Reproductive Medicine
https://read.qxmd.com/read/38710530/clinical-characteristics-and-status-of-treatment-of-small-cell-carcinoma-of-the-ovary-hypercalcemic-type-in-the-chinese-population-a-meta-analysis
#2
JOURNAL ARTICLE
Kewei Zheng, Yi Gao, Congjian Xu, Yu Kang
OBJECTIVE: This study aimed to comprehensively analyze the clinical characteristics and treatment status of Chinese small cell carcinoma of the ovary hypercalcemic type (SCCOHT) patients, providing insights into this unique population and comparing findings with international literature. METHODS: Through a meta-analysis, we collected data from published case reports and records from the Obstetrics & Gynecology Hospital of Fudan University. Demographic information, clinical presentations, tumor attributes, treatment modalities, and survival outcomes were extracted and examined alongside relevant global studies...
April 17, 2024: Journal of Gynecologic Oncology
https://read.qxmd.com/read/38710529/perioperative-outcomes-and-platinum-resistant-recurrence-in-patients-undergoing-systematic-protocol-based-total-parietal-peritonectomy-during-interval-cytoreductive-surgery-for-advanced-ovarian-cancer-results-of-the-torpedo-study
#3
JOURNAL ARTICLE
Aditi Bhatt, Snita Sinukumar, Dileep Damodaran, Loma Parikh, Gaurav Goswami, Sanket Mehta, Praveen Kammar
OBJECTIVE: The TORPEDO (CTRI/2018/12/016789) is the single-arm, prospective, interventional study evaluating the role of a total parietal peritonectomy (TPP) in patients undergoing interval cytoreductive surgery (iCRS). In this manuscript, we report the perioperative outcomes and platinum resistant recurrence (PRR) in 218 patients enrolled in the study. METHODS: A TPP was performed in all patients undergoing iCRS irrespective of the residual disease extent. hyperthermic intraperitoneal chemotherapy (HIPEC) was performed as per the clinician's discretion with 75 mg/m² of cisplatin...
April 23, 2024: Journal of Gynecologic Oncology
https://read.qxmd.com/read/38709075/pan-cancer-interrogation-of-b7-h3-cd276-as-an-actionable-therapeutic-target-across-human-malignancies
#4
JOURNAL ARTICLE
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Neeraj Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S Hoon, Jacob J Orme, Oliver Sartor, Ari Vanderwalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
B7-H3 (CD276) is a transmembrane glycoprotein of the B7 immune checkpoint superfamily that has emerged as a promising therapeutic target. To better understand the applicability of B7-H3-directed therapies, we analyzed 156,791 samples comprising 50 cancer types to interrogate the clinical, genomic, transcriptomic, and immunological correlates of B7-H3 mRNA expression. DNA (592-gene/whole-exome) and RNA (whole-transcriptome) sequencing was performed from samples submitted to Caris Life Sciences (Phoenix, AZ)...
May 6, 2024: Cancer Res Commun
https://read.qxmd.com/read/38708335/magnetic-resonance-imaging-findings-of-a-case-with-wolffian-tumor-and-related-literature-review
#5
JOURNAL ARTICLE
Can Cui, Dawei Cui, Jiangfeng Pan, Shaobin Zhou, Xiujuan Zheng
BACKGROUND: Wolffian tumors in females are rare gynecological neoplasms, with fewer than 100 cases reported. Existing literature primarily focuses on the pathology, and reports involving imaging are limited. OBJECTIVE: This study presents a case of Wolffian tumor, emphasizing its magnetic resonance imaging (MRI) characteristics to enhance preoperative diagnostic accuracy. CASE REPORT: A 56-year-old woman presented with a year-long history of irregular vaginal bleeding...
April 2024: Asian Biomedicine: Research, Reviews and News
https://read.qxmd.com/read/38707031/story-of-20-years-of-triumph-a-case-report-of-two-patients-with-stage-iv-granulosa-cell-tumor-of-the-ovary
#6
Sameen Bin Naeem, Maryam Imran, Mansoor Abbas, Muhammad Awais Majeed, Muhammad Ahsan Jamil, Mahnoor Samreen, Neelam Siddiqui
Ovarian granulosa cell tumors (GCTs) are rare neoplasms with a unique incidence pattern peaking in postmenopausal women. This case report presents two instances of stage 4 recurrent adult GCTs with a prolonged 20-year follow-up. Patient 1, diagnosed at 54 years, experienced multiple recurrences managed through surgery, hormonal therapy, and chemotherapy, culminating in hepatocellular carcinoma. Patient 2, diagnosed at 67 years, underwent various treatments, including surgery, chemotherapy, and hormonal therapy, demonstrating disease stability...
April 2024: Curēus
https://read.qxmd.com/read/38706491/early-onset-severe-ovarian-endometriosis-in-adolescents-with-completely-obstructed-m%C3%A3-llerian-anomalies-accompanied-by-ipsilateral-renal-agenesis-two-case-reports
#7
Bo Ram Yu, Hee-Suk Chae, Chul-Hee Rheu
Endometriosis is known to occur frequently in adolescents with obstructed Müllerian anomalies. Our cases emphasize that endometriosis can rapidly progress to a severe stage in obstructed hemivagina and ipsilateral renal anomaly syndrome, one of the completely obstructed Müllerian anomalies. The first patient was a 14-year-old girl who complained of cyclic abdominal pain. Imaging revealed a uterine didelphys with unilateral hematocolpos and a left adnexal endometrioma. The second, an 11-year-old girl, visited the hospital complaining of cyclic abdominal pain, had a unicornuate uterus with a functioning horn and left adnexal endometrioma...
May 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38706364/resveratrol-in-the-treatment-of-gynecological-cancer-mechanisms-and-therapeutic-potential
#8
JOURNAL ARTICLE
Mohammad Javad Mozafaryan, Pouria Rezaei, Fardin Masoudpoor, Amirmohammad Bahri, Mohammad Samini, Tahere Farkhondeh, Mohammad Hossein Pourhanifeh, Saeed Samarghandian
Gynecological cancers, encompassing endometrial, ovarian, and cervical cancer, pose significant challenges in clinical practice, often marked by high mortality rates and treatment resistance. Despite advances in standard therapies, including chemoradiation and surgery, tumor recurrence and metastasis remain formidable obstacles. In this context, there is a pressing need to explore novel therapeutic strategies that offer improved efficacy and reduced side effects. Herbal medicine, particularly compounds like resveratrol, has garnered attention for its diverse biological properties, including anticancer effects...
May 3, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38706262/pir-1919609-is-an-ideal-potential-target-for-reversing-platinum-resistance-in-ovarian-cancer
#9
JOURNAL ARTICLE
Ying Yan, Dan Tian, Bingbing Zhao, Zhuang Li, Zhijiong Huang, Kuina Li, Xiaoqi Chen, Lu Zhou, Yanying Feng, Zhijun Yang
PURPOSE: PIWI-interacting RNAs (piRNAs) are a type of noncoding small RNA that can interact with PIWI-like RNA-mediated gene silencing (PIWIL) proteins to affect biological processes such as transposon silencing through epigenetic effects. Recent studies have found that piRNAs are widely dysregulated in tumors and associated with tumor progression and a poor prognosis. Therefore, this study aimed to investigate the effect of piR-1919609 on the proliferation, apoptosis, and drug resistance of ovarian cancer cells...
2024: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/38705138/postoperative-reproductive-outcomes-in-patients-with-endometriosis-associated-infertility-a-single-centre-retrospective-study
#10
JOURNAL ARTICLE
Khayal Gasimli, Dilara Akpinar, Bahar Gasimli, Annette Bachmann, Norbert Maczó, Rudy Leon De Wilde, Antoine Naem, Harald Krentel, Sven Becker, Morva Tahmasbi Rad
OBJECTIVES: Endometriosis is a chronic inflammatory disease known to contribute to infertility. Laparoscopic excision of endometriotic lesions represents a standard treatment modality for symptomatic women. Our study aims to assess the potential benefits of laparoscopic excision of endometriosis in patients experiencing infertility associated with the condition, as well as to define the clinical factors that may impact the cumulative pregnancy rate. DESIGN: In this retrospective analysis, a total of 102 patients with endometriosis-related infertility were enrolled...
May 3, 2024: Gynecologic and Obstetric Investigation
https://read.qxmd.com/read/38704898/outcomes-of-secondary-cytoreductive-surgery-in-patients-with-platinum-sensitive-recurrent-ovarian-cancer-progressed-after-prior-poly-adenosine-diphosphate-ribose-polymerase-inhibitors-a-retrospective-cohort-study
#11
JOURNAL ARTICLE
Yuxi Zhao, Hua Yuan, Yiran Chen, Hongwen Yao, Ning Li, Lingying Wu, Guangwen Yuan
OBJECTIVE: To evaluate the impact of previous poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor therapy on the effectiveness of secondary cytoreductive surgery (SCS) in patients with platinum-sensitive recurrent ovarian cancer (PSROC). METHODS: We identified patients with PSROC who underwent SCS at the Cancer Hospital, Chinese Academy of Medical Science, between January 2010 and December 2022. Postoperative complications within 30 days were categorized using the Accordion Severity Grading System...
May 3, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38701316/efficacy-and-safety-of-pd-1-pd-l1-immune-checkpoint-inhibitors-in-the-treatment-of-recurrent-ovarian-cancer-a-systematic-review-and-meta-analysis
#12
JOURNAL ARTICLE
Yafang Chen, Xiaomei Liu, Ying Hu, Lingling Xia
BACKGROUND: Recurrent ovarian cancer (OC) presents a significant therapeutic challenge with limited treatment success. Programmed cell death protein 1 (PD-1/PD-L1) immune checkpoint inhibitors have emerged as a potential treatment avenue, necessitating a systematic review and meta-analysis to evaluate their efficacy and safety. METHODS: Adhering to preferred reporting items for systematic reviews and meta-analyses guidelines, we conducted a comprehensive literature search across PubMed, Embase, Web of Science, and Cochrane Library, culminating in the inclusion of studies focusing on the treatment of recurrent OC with PD-1/PD-L1 inhibitors...
May 3, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38701311/nongestational-ovarian-choriocarcinoma-with-bilateral-teratoma-a-rare-case-report-and-literature-review
#13
REVIEW
Xue Ao, Sha Hu, Shiqiao Tan, Wei Xiong
INTRODUCTION: Trophoblastic neoplasms are often associated with pregnancy, and nongestational trophoblastic neoplasms are extremely rare. Nongestational ovarian choriocarcinoma (NGCO) is a highly aggressive germ cell-derived tumor frequently presenting with early hematogenous metastasis. PATIENT CONCERNS: Herein, we report a case of a 28-year-old unmarried woman with regular menstruation who experienced vaginal bleeding 1 week after her last menstrual cycle. Doppler ultrasound revealed bilateral adnexal masses and elevated serum human chorionic gonadotropin (hCG) levels...
May 3, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38693025/preoperative-cect-based-multitask-model-predicts-peritoneal-recurrence-and-disease-free-survival-in-advanced-ovarian-cancer-a%C3%A2-multicenter-study
#14
JOURNAL ARTICLE
Rui Yin, Zhaoxiang Dou, Yanyan Wang, Qian Zhang, Yijun Guo, Yigeng Wang, Ying Chen, Chao Zhang, Huiyang Li, Xiqi Jian, Lisha Qi, Wenjuan Ma
RATIONALE AND OBJECTIVES: Peritoneal recurrence is the predominant pattern of recurrence in advanced ovarian cancer (AOC) and portends a dismal prognosis. Accurate prediction of peritoneal recurrence and disease-free survival (DFS) is crucial to identify patients who might benefit from intensive treatment. We aimed to develop a predictive model for peritoneal recurrence and prognosis in AOC. METHODS: In this retrospective multi-institution study of 515 patients, an end-to-end multi-task convolutional neural network (MCNN) comprising a segmentation convolutional neural network (CNN) and a classification CNN was developed and tested using preoperative CT images, and MCNN-score was generated to indicate the peritoneal recurrence and DFS status in patients with AOC...
April 30, 2024: Academic Radiology
https://read.qxmd.com/read/38689097/long-term-oncologic-outcomes-of-unselected-triple-negative-breast-cancer-patients-according-to-brca1-2-mutations
#15
JOURNAL ARTICLE
Woong Ki Park, Soo Yeon Chung, You Jin Jung, Changhee Ha, Jong-Won Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jeong Eon Lee, Sung-Won Kim, Jai Min Ryu
Triple-negative breast cancer (TNBC) patients are more likely to have BRCA1/2 mutations, with a prevalence rate of about 10-20%. Although several studies have analyzed the oncologic outcomes between BRCA1/2 carriers and non-carriers, the impact on breast cancer patients is still unclear. A retrospective review was performed to determine the long-term outcomes of TNBC patients, focusing on the impact of BRCA1/2 mutations. A total of 953 TNBC patients who underwent primary breast cancer surgery from June 2008 to January 2016 were included...
April 30, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38688599/impact-of-bevacizumab-on-clinical-outcomes-in-patients-with-platinum-resistant-relapsed-ovarian-cancer
#16
JOURNAL ARTICLE
Aeran Seol, Se Ik Kim, Hee Yeun Yoon, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Noh Hyun Park, Yong Sang Song
BACKGROUND/AIM: Over the past several decades, new anti-cancer drugs have been developed for the treatment of epithelial ovarian cancer. The development of drugs has led to changes in improving the prognosis of ovarian cancer patients. One of these drugs, bevacizumab, is used for advanced or recurrent ovarian cancer. In this study, we aimed to evaluate survival improvement in patients with platinum-resistant relapsed epithelial ovarian cancer (PR-ROC) after introduction of bevacizumab in real world experience...
2024: In Vivo
https://read.qxmd.com/read/38686518/treating-benign-ovarian-lesions-in-the-pediatric-population-a-single-institution-s-retrospective-investigation-of-laparoscopy-versus-open-repair
#17
JOURNAL ARTICLE
Nicole Chicoine, Niloufar Hafezi, Victoria Sanchez, Victoria Elliott, Brian Gray
Background: Benign ovarian lesions in the pediatric population have variable risk of recurrence or development of metachronous lesions, leading to variations in operative approach. Our study compares outcomes with differing surgical approaches to better elucidate risk of recurrent or metachronous lesions, time to development of these lesions, and hospital length of stay to determine if one operative approach has superior outcomes. Methods: We retrospectively examined data from Indiana University Health facilities from 2002 to 2020...
April 30, 2024: Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
https://read.qxmd.com/read/38679485/olaparib-and-niraparib-as-maintenance-therapy-in-patients-with-newly-diagnosed-and-platinum-sensitive-recurrent-ovarian-cancer-a-single-center-study-in-china
#18
JOURNAL ARTICLE
Dengfeng Wang, Xunwei Shi, Jiao Pei, Can Zhang, Liping Peng, Jie Zhang, Jing Zheng, Chunrong Peng, Xiaoqiao Huang, Xiaoshi Liu, Hong Liu, Guonan Zhang
BACKGROUND: Poly adenosine-diphosphate-ribose polymerase (PARP) inhibitors (PARPi) have been approved to act as first-line maintenance (FL-M) therapy and as platinum-sensitive recurrent maintenance (PSR-M) therapy for ovarian cancer in China for >5 years. Herein, we have analyzed the clinical-application characteristics of olaparib and niraparib in ovarian cancer-maintenance therapy in a real-world setting to strengthen our understanding and promote their rational usage. METHODS: A retrospective chart review identified patients with newly diagnosed or platinum-sensitive recurrent ovarian cancer, who received olaparib or niraparib as maintenance therapy at Sichuan Cancer Hospital between August 1, 2018, and December 31, 2021...
April 26, 2024: Chinese Medical Journal
https://read.qxmd.com/read/38679402/dostarlimab-review-on-success-story-and-clinical-trials
#19
REVIEW
Rohitash Yadav, Ishita Mathur, Hoineiting Rebecca Haokip, Avaneesh K Pandey, Vinod Kumar, Neeraj Jain
The PD-1/PD-L1 pathway plays a significant role in inhibiting, escaping from immune response, and promoting self-tolerance of the tumour. Dostarlimab is a selective humanized monoclonal antibody designed to target PD-1 and block its activity with PD-L1, which further prevents the escape of tumour cells from immune surveillance. It got accelerated approval from the FDA for treating adults with mismatch repair deficient, recurrent, or advanced endometrial cancer, and studies confirmed its beneficial effects. A recently published clinical trial reported 100% remission of advanced rectal cancer without significant side effects in the participants...
April 26, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38672549/imaging-of-peritoneal-metastases-in-ovarian-cancer-using-mdct-mri-and-fdg-pet-ct-a-systematic-review-and-meta-analysis
#20
REVIEW
Athina C Tsili, George Alexiou, Martha Tzoumpa, Timoleon Siempis, Maria I Argyropoulou
This review aims to compare the diagnostic performance of multidetector CT (MDCT), MRI, including diffusion-weighted imaging, and FDG PET/CT in the detection of peritoneal metastases (PMs) in ovarian cancer (OC). A comprehensive search was performed for articles published from 2000 to February 2023. The inclusion criteria were the following: diagnosis/suspicion of PMs in patients with ovarian/fallopian/primary peritoneal cancer; initial staging or suspicion of recurrence; MDCT, MRI and/or FDG PET/CT performed for the detection of PMs; population of at least 10 patients; surgical results, histopathologic analysis, and/or radiologic follow-up, used as reference standard; and per-patient and per-region data and data for calculating sensitivity and specificity reported...
April 11, 2024: Cancers
keyword
keyword
103066
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.